Teladoc Health, Inc. (TDOC) stock
TDOCNYSEServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3043% below fair value
$8.06−0.43 (-5.06%)
Close on Nov 18, 2026Market cap $1.47BP/E –Yield –
Teladoc Health operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Teladoc Health's operating income for the twelve months ending Sep 30, 2026 was -$162.96M. For fiscal 2025 it was -$262.96M. The highest annual figure on record is -$5.87M in fiscal 2013.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$262.96M | – |
| FY2024 | Dec 31, 2024 | -$1.02B | – |
| FY2023 | Dec 31, 2023 | -$248.55M | – |
| FY2022 | Dec 31, 2022 | -$13.65B | – |
| FY2021 | Dec 31, 2021 | -$265.63M | – |
| FY2020 | Dec 31, 2020 | -$506.42M | – |
| FY2019 | Dec 31, 2019 | -$80.44M | – |
| FY2018 | Dec 31, 2018 | -$70.85M | – |
| FY2017 | Dec 31, 2017 | -$75.39M | – |
| FY2016 | Dec 31, 2016 | -$62.66M | – |
| FY2015 | Dec 31, 2015 | -$55.79M | – |
| FY2014 | Dec 31, 2014 | -$15.15M | – |
| FY2013 | Dec 31, 2013 | -$5.87M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$28.10M | – |
| Q2 FY2026 | Jun 30, 2026 | -$37.09M | – |
| Q1 FY2026 | Mar 31, 2026 | -$61.77M | – |
| Q4 FY2025 | Dec 31, 2025 | -$36.00M | – |
| Q3 FY2025 | Sep 30, 2025 | -$51.96M | – |
| Q2 FY2025 | Jun 30, 2025 | -$54.39M | – |
| Q1 FY2025 | Mar 31, 2025 | -$120.61M | – |
| Q4 FY2024 | Dec 31, 2024 | -$48.22M | – |
| Q3 FY2024 | Sep 30, 2024 | -$44.40M | – |
| Q2 FY2024 | Jun 30, 2024 | -$841.15M | – |
| Q1 FY2024 | Mar 31, 2024 | -$87.12M | – |
| Q4 FY2023 | Dec 31, 2023 | -$35.08M | – |
| Q3 FY2023 | Sep 30, 2023 | -$64.73M | – |
| Q2 FY2023 | Jun 30, 2023 | -$71.65M | – |
| Q1 FY2023 | Mar 31, 2023 | -$77.10M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.82B | – |
| Q3 FY2022 | Sep 30, 2022 | -$71.73M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.10B | – |
| Q1 FY2022 | Mar 31, 2022 | -$6.67B | – |
| Q4 FY2021 | Dec 31, 2021 | -$41.43M | – |
| Q3 FY2021 | Sep 30, 2021 | -$60.58M | – |
| Q2 FY2021 | Jun 30, 2021 | -$78.95M | – |
| Q1 FY2021 | Mar 31, 2021 | -$84.68M | – |
| Q4 FY2020 | Dec 31, 2020 | -$458.51M | – |
| Q3 FY2020 | Sep 30, 2020 | -$19.73M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.18M | – |
| Q1 FY2020 | Mar 31, 2020 | -$21.01M | – |
| Q4 FY2019 | Dec 31, 2019 | -$15.59M | – |
| Q3 FY2019 | Sep 30, 2019 | -$19.94M | – |
| Q2 FY2019 | Jun 30, 2019 | -$22.02M | – |
| Q1 FY2019 | Mar 31, 2019 | -$22.89M | – |
| Q4 FY2018 | Dec 31, 2018 | -$17.84M | – |
| Q3 FY2018 | Sep 30, 2018 | -$15.78M | – |
| Q2 FY2018 | Jun 30, 2018 | -$18.15M | – |
| Q1 FY2018 | Mar 31, 2018 | -$19.09M | – |
| Q4 FY2017 | Dec 31, 2017 | -$24.56M | – |
| Q3 FY2017 | Sep 30, 2017 | -$21.54M | – |
| Q2 FY2017 | Jun 30, 2017 | -$14.49M | – |
| Q1 FY2017 | Mar 31, 2017 | -$14.80M | – |
| Q4 FY2016 | Dec 31, 2016 | -$13.23M | – |
See a number that looks wrong?